Early effects of insulin-like growth factor-1 in activated human T lymphocytes

This study evaluates the effects of insulin-like growth factor (IGF)-1 receptor (IGF-1R) down-regulation in stimulated T lymphocytes by investigating the expression of early activation proteins CD69, CD25, and interleukin (IL)-2. We found that IGF-1 does not modify CD69 expression but increases tran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 2001
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07415400_v70_n2_p297_Brocardo
http://hdl.handle.net/20.500.12110/paper_07415400_v70_n2_p297_Brocardo
Aporte de:
id paper:paper_07415400_v70_n2_p297_Brocardo
record_format dspace
spelling paper:paper_07415400_v70_n2_p297_Brocardo2023-06-08T15:44:40Z Early effects of insulin-like growth factor-1 in activated human T lymphocytes CD25 IGF-1 mRNA IGF-1 receptor IL-2 MAPK CD69 antigen interleukin 2 interleukin 2 receptor microtubule associated protein protein kinase (calcium,calmodulin) somatomedin C somatomedin C receptor transcription factor transcription factor ea transcription factor eb unclassified drug antigen expression article autocrine effect controlled study human human cell immunostimulation insulin like activity leukemia cell line microtubule assembly paracrine signaling pathophysiology priority journal protein expression protein modification protein phosphorylation protein synthesis receptor down regulation T lymphocyte activation transcription regulation Antigens, CD Antigens, Differentiation, T-Lymphocyte Down-Regulation Humans Immediate-Early Proteins Insulin-Like Growth Factor I Interleukin-2 Jurkat Cells Kinetics Lymphocyte Activation Mitogen-Activated Protein Kinases Receptor, IGF Type 1 Receptors, Interleukin-2 RNA, Messenger T-Lymphocytes Transcription, Genetic This study evaluates the effects of insulin-like growth factor (IGF)-1 receptor (IGF-1R) down-regulation in stimulated T lymphocytes by investigating the expression of early activation proteins CD69, CD25, and interleukin (IL)-2. We found that IGF-1 does not modify CD69 expression but increases transcription and protein synthesis of CD25 and IL-2. The lowest level of IGF-1R detected after 15 min of activation suggested that the effects of IGF-1 occur at the initiation of cell activation. The activation of IGF-1R was confirmed by IGF-1R phosphorylation and increased phosphorylation of microtubule-associated protein kinase. We also detected the alternative IGF-1 transcripts Ea, with paracrine/autocrine regulation, and Eb, with endocrine regulation, in Jurkat cells and in quiescent T lymphocytes, and we detected IGF-1 protein in the culture medium after stimulation. These data suggest that the proliferative effects of IGF-1 on T lymphocytes include both autocrine/paracrine and endocrine processes. 2001 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07415400_v70_n2_p297_Brocardo http://hdl.handle.net/20.500.12110/paper_07415400_v70_n2_p297_Brocardo
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic CD25
IGF-1 mRNA
IGF-1 receptor
IL-2
MAPK
CD69 antigen
interleukin 2
interleukin 2 receptor
microtubule associated protein
protein kinase (calcium,calmodulin)
somatomedin C
somatomedin C receptor
transcription factor
transcription factor ea
transcription factor eb
unclassified drug
antigen expression
article
autocrine effect
controlled study
human
human cell
immunostimulation
insulin like activity
leukemia cell line
microtubule assembly
paracrine signaling
pathophysiology
priority journal
protein expression
protein modification
protein phosphorylation
protein synthesis
receptor down regulation
T lymphocyte activation
transcription regulation
Antigens, CD
Antigens, Differentiation, T-Lymphocyte
Down-Regulation
Humans
Immediate-Early Proteins
Insulin-Like Growth Factor I
Interleukin-2
Jurkat Cells
Kinetics
Lymphocyte Activation
Mitogen-Activated Protein Kinases
Receptor, IGF Type 1
Receptors, Interleukin-2
RNA, Messenger
T-Lymphocytes
Transcription, Genetic
spellingShingle CD25
IGF-1 mRNA
IGF-1 receptor
IL-2
MAPK
CD69 antigen
interleukin 2
interleukin 2 receptor
microtubule associated protein
protein kinase (calcium,calmodulin)
somatomedin C
somatomedin C receptor
transcription factor
transcription factor ea
transcription factor eb
unclassified drug
antigen expression
article
autocrine effect
controlled study
human
human cell
immunostimulation
insulin like activity
leukemia cell line
microtubule assembly
paracrine signaling
pathophysiology
priority journal
protein expression
protein modification
protein phosphorylation
protein synthesis
receptor down regulation
T lymphocyte activation
transcription regulation
Antigens, CD
Antigens, Differentiation, T-Lymphocyte
Down-Regulation
Humans
Immediate-Early Proteins
Insulin-Like Growth Factor I
Interleukin-2
Jurkat Cells
Kinetics
Lymphocyte Activation
Mitogen-Activated Protein Kinases
Receptor, IGF Type 1
Receptors, Interleukin-2
RNA, Messenger
T-Lymphocytes
Transcription, Genetic
Early effects of insulin-like growth factor-1 in activated human T lymphocytes
topic_facet CD25
IGF-1 mRNA
IGF-1 receptor
IL-2
MAPK
CD69 antigen
interleukin 2
interleukin 2 receptor
microtubule associated protein
protein kinase (calcium,calmodulin)
somatomedin C
somatomedin C receptor
transcription factor
transcription factor ea
transcription factor eb
unclassified drug
antigen expression
article
autocrine effect
controlled study
human
human cell
immunostimulation
insulin like activity
leukemia cell line
microtubule assembly
paracrine signaling
pathophysiology
priority journal
protein expression
protein modification
protein phosphorylation
protein synthesis
receptor down regulation
T lymphocyte activation
transcription regulation
Antigens, CD
Antigens, Differentiation, T-Lymphocyte
Down-Regulation
Humans
Immediate-Early Proteins
Insulin-Like Growth Factor I
Interleukin-2
Jurkat Cells
Kinetics
Lymphocyte Activation
Mitogen-Activated Protein Kinases
Receptor, IGF Type 1
Receptors, Interleukin-2
RNA, Messenger
T-Lymphocytes
Transcription, Genetic
description This study evaluates the effects of insulin-like growth factor (IGF)-1 receptor (IGF-1R) down-regulation in stimulated T lymphocytes by investigating the expression of early activation proteins CD69, CD25, and interleukin (IL)-2. We found that IGF-1 does not modify CD69 expression but increases transcription and protein synthesis of CD25 and IL-2. The lowest level of IGF-1R detected after 15 min of activation suggested that the effects of IGF-1 occur at the initiation of cell activation. The activation of IGF-1R was confirmed by IGF-1R phosphorylation and increased phosphorylation of microtubule-associated protein kinase. We also detected the alternative IGF-1 transcripts Ea, with paracrine/autocrine regulation, and Eb, with endocrine regulation, in Jurkat cells and in quiescent T lymphocytes, and we detected IGF-1 protein in the culture medium after stimulation. These data suggest that the proliferative effects of IGF-1 on T lymphocytes include both autocrine/paracrine and endocrine processes.
title Early effects of insulin-like growth factor-1 in activated human T lymphocytes
title_short Early effects of insulin-like growth factor-1 in activated human T lymphocytes
title_full Early effects of insulin-like growth factor-1 in activated human T lymphocytes
title_fullStr Early effects of insulin-like growth factor-1 in activated human T lymphocytes
title_full_unstemmed Early effects of insulin-like growth factor-1 in activated human T lymphocytes
title_sort early effects of insulin-like growth factor-1 in activated human t lymphocytes
publishDate 2001
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_07415400_v70_n2_p297_Brocardo
http://hdl.handle.net/20.500.12110/paper_07415400_v70_n2_p297_Brocardo
_version_ 1768544415722242048